Literature DB >> 23776214

Architecture of respiratory syncytial virus revealed by electron cryotomography.

Lassi Liljeroos1, Magdalena Anna Krzyzaniak, Ari Helenius, Sarah Jane Butcher.   

Abstract

Human respiratory syncytial virus is a human pathogen that causes severe infection of the respiratory tract. Current information about the structure of the virus and its interaction with host cells is limited. We carried out an electron cryotomographic characterization of cell culture-grown human respiratory syncytial virus to determine the architecture of the virion. The particles ranged from 100 nm to 1,000 nm in diameter and were spherical, filamentous, or a combination of the two. The filamentous morphology correlated with the presence of a cylindrical matrix protein layer linked to the inner leaflet of the viral envelope and with local ordering of the glycoprotein spikes. Recombinant viruses with only the fusion protein in their envelope showed that these glycoproteins were predominantly in the postfusion conformation, but some were also in the prefusion form. The ribonucleocapsids were left-handed, randomly oriented, and curved inside the virions. In filamentous particles, they were often adjacent to an intermediate layer of protein assigned to M2-1 (an envelope-associated protein known to mediate association of ribonucleocapsids with the matrix protein). Our results indicate important differences in structure between the Paramyxovirinae and Pneumovirinae subfamilies within the Paramyxoviridae, and provide fresh insights into host cell exit of a serious pathogen.

Entities:  

Keywords:  cryo-ET; paramyxovirus; virus structure

Mesh:

Substances:

Year:  2013        PMID: 23776214      PMCID: PMC3703984          DOI: 10.1073/pnas.1309070110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The 12 A structure of trypsin-treated measles virus N-RNA.

Authors:  Guy Schoehn; Manos Mavrakis; Aurélie Albertini; Richard Wade; Andreas Hoenger; Rob W H Ruigrok
Journal:  J Mol Biol       Date:  2004-05-28       Impact factor: 5.469

2.  Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene.

Authors:  S Techaarpornkul; N Barretto; M E Peeples
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Computer visualization of three-dimensional image data using IMOD.

Authors:  J R Kremer; D N Mastronarde; J R McIntosh
Journal:  J Struct Biol       Date:  1996 Jan-Feb       Impact factor: 2.867

4.  Characterization of the 10 proteins of human respiratory syncytial virus: identification of a fourth envelope-associated protein.

Authors:  Y T Huang; P L Collins; G W Wertz
Journal:  Virus Res       Date:  1985-03       Impact factor: 3.303

5.  Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

Authors: 
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

7.  Respiratory syncytial virus infection in elderly and high-risk adults.

Authors:  Ann R Falsey; Patricia A Hennessey; Maria A Formica; Christopher Cox; Edward E Walsh
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

8.  The envelope-associated 22K protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript.

Authors:  P L Collins; G W Wertz
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

9.  Morphogenesis and ultrastructure of respiratory syncytial virus.

Authors:  T Bächi; C Howe
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

10.  A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles.

Authors:  Fyza Y Shaikh; Reagan G Cox; Aaron W Lifland; Anne L Hotard; John V Williams; Martin L Moore; Philip J Santangelo; James E Crowe
Journal:  MBio       Date:  2012-02-07       Impact factor: 7.867

View more
  94 in total

Review 1.  Imaging viral RNA using multiply labeled tetravalent RNA imaging probes in live cells.

Authors:  Eric Alonas; Daryll Vanover; Emmeline Blanchard; Chiara Zurla; Philip J Santangelo
Journal:  Methods       Date:  2016-02-12       Impact factor: 3.608

Review 2.  Conformational plasticity of the Ebola virus matrix protein.

Authors:  Jens Radzimanowski; Gregory Effantin; Winfried Weissenhorn
Journal:  Protein Sci       Date:  2014-09-04       Impact factor: 6.725

3.  Biochemical characterization of the respiratory syncytial virus N0-P complex in solution.

Authors:  Camille Esneau; Bertrand Raynal; Pierre Roblin; Sébastien Brûlé; Charles-Adrien Richard; Jenna Fix; Jean-François Eléouët; Marie Galloux
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

4.  Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.

Authors:  Lori McGinnes Cullen; Madelyn R Schmidt; Sarah A Kenward; Robert T Woodland; Trudy G Morrison
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

Review 5.  What Are the Most Powerful Immunogen Design Vaccine Strategies? A Structural Biologist's Perspective.

Authors:  Peter D Kwong
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

6.  Interaction of Human Parainfluenza Virus Type 3 Nucleoprotein with Matrix Protein Mediates Internal Viral Protein Assembly.

Authors:  Guangyuan Zhang; Yi Zhong; Yali Qin; Mingzhou Chen
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.

Authors:  Jason S McLellan; Man Chen; M Gordon Joyce; Mallika Sastry; Guillaume B E Stewart-Jones; Yongping Yang; Baoshan Zhang; Lei Chen; Sanjay Srivatsan; Anqi Zheng; Tongqing Zhou; Kevin W Graepel; Azad Kumar; Syed Moin; Jeffrey C Boyington; Gwo-Yu Chuang; Cinque Soto; Ulrich Baxa; Arjen Q Bakker; Hergen Spits; Tim Beaumont; Zizheng Zheng; Ningshao Xia; Sung-Youl Ko; John-Paul Todd; Srinivas Rao; Barney S Graham; Peter D Kwong
Journal:  Science       Date:  2013-11-01       Impact factor: 47.728

8.  Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex.

Authors:  Gabriella Kiss; Jens M Holl; Grant M Williams; Eric Alonas; Daryll Vanover; Aaron W Lifland; Manasa Gudheti; Ricardo C Guerrero-Ferreira; Vinod Nair; Hong Yi; Barney S Graham; Philip J Santangelo; Elizabeth R Wright
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

9.  Native immunogold labeling of cell surface proteins and viral glycoproteins for cryo-electron microscopy and cryo-electron tomography applications.

Authors:  Hong Yi; Joshua D Strauss; Zunlong Ke; Eric Alonas; Rebecca S Dillard; Cheri M Hampton; Kristen M Lamb; Jason E Hammonds; Philip J Santangelo; Paul W Spearman; Elizabeth R Wright
Journal:  J Histochem Cytochem       Date:  2015-06-11       Impact factor: 2.479

Review 10.  Neutralizing epitopes of RSV and palivizumab resistance in Japan.

Authors:  Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Fukushima J Med Sci       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.